Literature DB >> 23867312

Hepatic menin recruits SIRT1 to control liver steatosis through histone deacetylation.

Yanan Cao1, Ying Xue, Lu Xue, Xiuli Jiang, Xiaolin Wang, Zhijian Zhang, Jian Yang, Jieli Lu, Changxian Zhang, Weiqing Wang, Guang Ning.   

Abstract

BACKGROUND & AIMS: The development and progression of non-alcoholic fatty liver disease are associated with aging, obesity, and type 2 diabetes. Understanding the precise regulatory networks of this process will contribute to novel therapeutic strategies.
METHODS: Hepatocyte-specific Men1 knockout mice were generated using Cre/loxP technology. Lipid and glucose metabolic phenotypes and mechanisms were investigated in aging and high-fat diet fed mice.
RESULTS: The expression of menin, encoded by multiple endocrine neoplasia 1 (Men1) gene, is reduced in the liver of aging mice. Hepatocyte-specific deletion of Men1 induces liver steatosis in aging mice. Menin deficiency promotes high-fat diet-induced liver steatosis in mice. Menin recruits SIRT1 to control hepatic CD36 expression and triglyceride accumulation through histone deacetylation.
CONCLUSIONS: Our work reveals that the adaptor protein menin is critical for the progression of hepatic steatosis during aging and metabolic imbalance.
Copyright © 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aging; HFD; Histone deacetylation; IPGTT; ITT; LMKO; Liver steatosis; MEN1; Menin; NAFLD; SIRT1; Scd-1; TC; TG; high-fat diet; insulin tolerance tests; intra-peritoneal glucose tolerance tests; liver-specific Men1 knockout mice; multiple endocrine neoplasia type 1; non-alcoholic fatty liver disease; stearoyl CoA desaturase-1; total cholesterol; triglyceride

Mesh:

Substances:

Year:  2013        PMID: 23867312     DOI: 10.1016/j.jhep.2013.07.011

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  20 in total

Review 1.  Genetic and epigenetic mechanisms of NASH.

Authors:  Mohammed Eslam; Jacob George
Journal:  Hepatol Int       Date:  2015-12-18       Impact factor: 6.047

2.  Aging aggravates alcoholic liver injury and fibrosis in mice by downregulating sirtuin 1 expression.

Authors:  Teresa Ramirez; Yong-Mei Li; Shi Yin; Ming-Jiang Xu; Dechun Feng; Zhou Zhou; Mengwei Zang; Partha Mukhopadhyay; Zoltan V Varga; Pal Pacher; Bin Gao; Hua Wang
Journal:  J Hepatol       Date:  2016-11-18       Impact factor: 25.083

Review 3.  A Review of the Scaffold Protein Menin and its Role in Hepatobiliary Pathology.

Authors:  Laurent Ehrlich; Chad Hall; Fanyin Meng; Terry Lairmore; Gianfranco Alpini; Shannon Glaser
Journal:  Gene Expr       Date:  2017-04-28

Review 4.  Twenty years of menin: emerging opportunities for restoration of transcriptional regulation in MEN1.

Authors:  Koen M A Dreijerink; H T Marc Timmers; Myles Brown
Journal:  Endocr Relat Cancer       Date:  2017-08-15       Impact factor: 5.678

5.  Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease.

Authors:  Weijun Wang; Jinfang Zhao; Wenfang Gui; Dan Sun; Haijiang Dai; Li Xiao; Huikuan Chu; Fan Du; Qingjing Zhu; Bernd Schnabl; Kai Huang; Ling Yang; Xiaohua Hou
Journal:  Br J Pharmacol       Date:  2018-01-03       Impact factor: 8.739

6.  Inhibition of microRNA-24 increases liver fibrosis by enhanced menin expression in Mdr2-/- mice.

Authors:  Chad Hall; Laurent Ehrlich; Fanyin Meng; Pietro Invernizzi; Francesca Bernuzzi; Terry C Lairmore; Gianfranco Alpini; Shannon Glaser
Journal:  J Surg Res       Date:  2017-05-11       Impact factor: 2.192

7.  Menin regulates lipid deposition in mouse hepatocytes via interacting with transcription factor FoxO1.

Authors:  Shengxuan Wang; Tingjun Liu; Lili Sun; Hongxia Du; Zhongjin Xu; Ranran Li; Ying Yu; Yongjiang Mao; Kerong Shi
Journal:  Mol Cell Biochem       Date:  2022-02-19       Impact factor: 3.396

Review 8.  Epigenetic Regulation of Hepatic Lipogenesis: Role in Hepatosteatosis and Diabetes.

Authors:  Jose Viscarra; Hei Sook Sul
Journal:  Diabetes       Date:  2020-04       Impact factor: 9.461

Review 9.  Histone deacetylase‑2: A potential regulator and therapeutic target in liver disease (Review).

Authors:  Ya-Ru Liu; Jie-Quan Wang; Zhao-Gang Huang; Ruo-Nan Chen; Xi Cao; Dong-Chun Zhu; Hai-Xia Yu; Xiu-Rong Wang; Hai-Yun Zhou; Quan Xia; Jun Li
Journal:  Int J Mol Med       Date:  2021-05-20       Impact factor: 4.101

10.  Targeting β-catenin signaling for therapeutic intervention in MEN1-deficient pancreatic neuroendocrine tumours.

Authors:  Xiuli Jiang; Yanan Cao; Feng Li; Yutong Su; Yanli Li; Ying Peng; Yulong Cheng; Changxian Zhang; Weiqing Wang; Guang Ning
Journal:  Nat Commun       Date:  2014-12-17       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.